Notice of Delisting or Failure to Satisfy Continued Listing Rule

Envoy Medical, Inc. received a notice from Nasdaq regarding non-compliance with the minimum bid price requirement. The company was initially given 180 days to regain compliance, but failed to do so by the deadline of May 18, 2026. However, Nasdaq has granted the company an additional 180-day period, until November 16, 2026, to meet the bid price requirement. This extension is contingent upon the company meeting other listing requirements and providing written notice of its intent to cure the deficiency, potentially through a reverse stock split. The company is also subject to risks related to market trade prices and the costs associated with addressing these compliance issues.